These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15343522)

  • 1. Prognostic factors in Bilharzial-related bladder cancer.
    Susani M; Haitel A; Marberger M
    Hum Pathol; 2004 Sep; 35(9):1167-8; author reply 1168. PubMed ID: 15343522
    [No Abstract]   [Full Text] [Related]  

  • 2. Muscle invasive schistosomal squamous cell carcinoma of the urinary bladder: frequency and prognostic significance of p53, BCL-2, HER2/neu, and proliferation (MIB-1).
    Badr KM; Nolen JD; Derose PB; Cohen C
    Hum Pathol; 2004 Feb; 35(2):184-9. PubMed ID: 14991535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
    J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multivariate analysis of survival, recurrence, progression and development of mestastasis in T1 and T2a transitional cell bladder carcinoma.
    Rodríguez-Alonso A; Pita-Fernández S; González-Carreró J; Nogueira-March JL
    Cancer; 2002 Mar; 94(6):1677-84. PubMed ID: 11920528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of cyclins, p53, and Ki-67 in cervical squamous cell carcinomas: overexpression of cyclin A is a poor prognostic factor in stage Ib and II disease.
    Shiohara S; Shiozawa T; Miyamoto T; Feng YZ; Kashima H; Kurai M; Suzuki A; Konishi I
    Virchows Arch; 2005 Jun; 446(6):626-33. PubMed ID: 15891905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of p53 and MDM2 expression in bilharziasis-associated squamous cell carcinoma of the urinary bladder.
    El-Kenawy Ael-M; El-Kott AF; Khalil AM
    Int J Biol Markers; 2003; 18(4):284-9. PubMed ID: 14756544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
    Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
    Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fascin is a predictor for invasiveness and recurrence of urothelial carcinoma of bladder.
    Bi J; Chen X; Zhang Y; Li B; Sun J; Shen H; Kong C
    Urol Oncol; 2012 Sep; 30(5):688-94. PubMed ID: 20888270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of p53 nuclear overexpression and MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder.
    Popov Z; Hoznek A; Colombel M; Bastuji-Garin S; Lefrere-Belda MA; Bellot J; Abboh CC; Mazerolles C; Chopin DK
    Cancer; 1997 Oct; 80(8):1472-81. PubMed ID: 9338472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of cyclin D1, but not cyclins E and A, is related to progression in bilharzial bladder cancer.
    Osman I; Scher H; Zhang ZF; Soos TJ; Hamza R; Eissa S; Khaled H; Koff A; Cordon-Cardo C
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2247-51. PubMed ID: 9815621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bcl-XL and Bcl-2 expression in bilharzial squamous cell carcinoma of the urinary bladder: which protein is prognostic?
    Hameed DA; Abdel Raheem AM; Mosad E; Hammouda HM; Kamel NA; Abdel Aziz MA
    Urology; 2008 Aug; 72(2):374-8. PubMed ID: 18342927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of protein p53 and ki-67 in invasive vulvar squamous cell carcinoma.
    Salmaso R; Zen T; Zannol M; Perin D; Marchiori S; Marchetti M
    Eur J Gynaecol Oncol; 2000; 21(5):479-83. PubMed ID: 11198037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of p53 and Ki-67 expression in intermediate-risk patients with nonmuscle-invasive bladder cancer receiving adjuvant intravesical mitomycin C therapy.
    Seo HK; Cho KS; Chung J; Joung JY; Park WS; Chung MK; Lee KH
    Urology; 2010 Aug; 76(2):512.e1-7. PubMed ID: 20579709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations affecting the p53 control pathway in bilharzial-related bladder cancer.
    Osman I; Scher HI; Zhang ZF; Pellicer I; Hamza R; Eissa S; Khaled H; Cordon-Cardo C
    Clin Cancer Res; 1997 Apr; 3(4):531-6. PubMed ID: 9815716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ki-67 and Cell Cycle Regulators p53, p63 and cyclinD1 as Prognostic Markers for Recurrence/ Progression of Bladder Urothelial Carcinoma.
    El-Gendi S; Abu-Sheasha G
    Pathol Oncol Res; 2018 Apr; 24(2):309-322. PubMed ID: 28488128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staging of carcinoma of bilharzial bladder.
    Ghoneim MA; Mansour MA; el-Bolkainy MN
    Urology; 1974 Jan; 3(1):40-2. PubMed ID: 4812896
    [No Abstract]   [Full Text] [Related]  

  • 17. Double squamous cell carcinomas, verrucous type and poorly differentiated type, of the urinary bladder unassociated with bilharzial infection.
    Oida Y; Yasuda M; Kajiwara H; Onda H; Kawamura N; Osamura RY
    Pathol Int; 1997 Sep; 47(9):651-4. PubMed ID: 9311020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of p53, p21/WAF1, Bcl-2, Bax, Bak and Ki-67 immunoreactivity in pT1 G3 urothelial bladder carcinomas.
    Wolf HK; Stöber C; Hohenfellner R; Leissner J
    Tumour Biol; 2001; 22(5):328-36. PubMed ID: 11553864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CD44 protein in bilharzial and non-bilharzial bladder cancers.
    Gadalla HA; Kamel NA; Badary FA; Elanany FG
    BJU Int; 2004 Jan; 93(1):151-5. PubMed ID: 14678388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of p53 nuclear overexpression in patients of muscle invasive urinary bladder carcinoma treated with cystectomy.
    Hemal AK; Khaitan A; Dinda AK; Gupta NP; Seth A; Dogra PN; Nabi G
    Urol Int; 2003; 70(1):42-6. PubMed ID: 12566814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.